Related Experiment Video
Updated: May 7, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma
11] Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden [2] Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
Abstract:
Deregulation of microRNA (miRNA) expression has been documented in diffuse large B-cell lymphoma (DLBCL). However, the impact of miRNAs and their machinery in DLBCL is not fully determined. Here, we assessed the role of miRNA expression and their processing genes in DLBCL development. Using microarray and RT-qPCR approaches, we quantified global miRNAs and core components of miRNA-processing genes expression in 75 DLBCLs (56 de novo and 19 transformed) and 10 lymph nodes (LN). Differential miRNA signatures were identified between DLBCLs and LNs, or between the de novo and transformed DLBCLs. We also identified subsets of miRNAs associated with germinal center B-cell phenotype, BCL6 and IRF4 expression, and clinical staging. In addition, we showed a significant over-expression of TARBP2 in de novo DLBCLs as compared with LNs, and decreased expression of DROSHA, DICER, TARBP2 and PACT in transformed as compared with de novo cases. Interestingly, cases with high TARBP2 and DROSHA expression had a poorer chemotherapy response. We further showed that TARBP2 can regulate miRNA-processing efficiency in DLBCLs, and its expression inhibition decreases cell growth and increases apoptosis in DLBCL cell lines. Our findings provide new insights for the understanding of miRNAs and its machinery in DLBCL.
Insights
MicroRNA (miRNA) processing genes like TARBP2 are altered in diffuse large B-cell lymphoma (DLBCL). High TARBP2 and DROSHA expression correlates with poor chemotherapy response, offering new therapeutic targets for DLBCL.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) deregulation is implicated in diffuse large B-cell lymphoma (DLBCL).
- The precise role of miRNA processing machinery in DLBCL pathogenesis remains unclear.
Purpose of the Study:
- To investigate the expression patterns of miRNAs and their processing genes in DLBCL.
- To determine the clinical significance of miRNA machinery alterations in DLBCL.
Main Methods:
- Microarray and RT-qPCR were used to quantify miRNA and miRNA-processing gene expression in 75 DLBCL samples and 10 lymph nodes.
- Differential expression analysis was performed to identify distinct miRNA signatures.
Main Results:
- Distinct miRNA signatures differentiated DLBCL from normal lymph nodes and de novo from transformed DLBCL.
- TARBP2 was overexpressed in de novo DLBCL, while DROSHA, DICER, TARBP2, and PACT were downregulated in transformed DLBCL.
- High TARBP2 and DROSHA expression correlated with poorer chemotherapy response.
Conclusions:
- miRNA processing gene alterations are associated with DLBCL subtypes and clinical outcomes.
- TARBP2 regulates miRNA processing and impacts DLBCL cell growth and apoptosis.
- These findings offer novel insights into the role of miRNA machinery in DLBCL and suggest potential therapeutic targets.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
07:23Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
The Intrinsic Apoptotic Pathway
Abnormal Proliferation